Matthew R. Silver

Davis Polk advised Banco Santander, S.A. in connection with its SEC-registered offering of $1.5 billion aggregate principal amount of 2.746% senior non-preferred fixed-rate notes due 2025…

Davis Polk advised MSCI Inc. in connection with a Rule 144A/Regulation S offering of $1.0 billion aggregate principal amount of its 3.875% senior notes due 2031. The notes are guaranteed by…

Davis Polk advised NatWest Markets Plc, a public limited company incorporated under the laws of Scotland, in connection with the update of its $10 billion 144A medium-term notes programme…

Davis Polk advised The Royal Bank of Scotland Group plc, a public limited company incorporated under the laws of Scotland, in connection with its SEC-registered shelf takedown of $1 billion…

Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $750 million of its 2.250% senior notes due 2030. MMC will use the net proceeds…

Davis Polk advised VF Corporation in connection with an SEC-registered debt shelf takedown of $1 billion aggregate principal amount of its 2.050% senior notes due 2022, $750 million…

Davis Polk advised Freeport-McMoRan Inc. (“FCX”) in connection with its SEC-registered offering of $1.3 billion of senior notes. The offering consisted of two tranches of senior notes,…

Davis Polk advised MSCI Inc. in connection with a Rule 144A/Regulation S offering of $400 million aggregate principal amount of its 3.625% senior notes due 2030. The notes are guaranteed by…

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Atara Biotherapeutics, Inc. of its common stock for up to an aggregate amount of $100 million. Based in…

Davis Polk advised VF Corporation in connection with an SEC-registered debt shelf takedown of €500 million aggregate principal amount of its 0.250% senior notes due 2028 (the “2028 notes”)…